期刊文献+

应用半乳糖凝集素-3、N末端B型利钠肽原和超声心动图评估心力衰竭患者心功能的比较研究 被引量:22

Comparison of Galectin-3,NT-proBNP and Echocardiography Parameters for Assessing Cardiac Function in Heart Failure Patients
下载PDF
导出
摘要 目的:应用半乳糖凝集素-3(Galectin-3,Gal-3)、N末端B型利钠肽原(NT-proBNP)和超声心动图指标,评估心力衰竭患者心功能,并比较不同指标评价心功能的能力。方法:入选2016-03至2016-11入住河北省人民医院的患者144例,根据纽约心脏协会(NYHA)心功能分级将患者分为心功能不全组72例和心功能正常组72例。收集入选者性别、年龄等临床基线资料,抽取静脉血测量血清Gal-3、血浆NT-proBNP水平以及超声心动图指标[左心室射血分数(LVEF)、左心室舒张末期内径(LVEDD))]。分析两组患者的基线资料,以及Gal-3、NT-proBNP和超声心动图指标之间的相关性,并比较三者判别心力衰竭患者的能力。结果:与心功能正常组比较,心功能不全组血浆NT-proBNP水平升高[3499.5(1431.3~9088.0)ng/L vs 384.1(122.1~1540.5)ng/L,P<0.05],血清Gal-3水平升高[3.0(1.71~5.8)pg/ml vs 1.9(1.4~2.6)pg/ml,P<0.05],LVEF降低[49.5%(42%~58%)vs 62.5%(59%~67%),P<0.05],LVEDD增大[52.0(46.3~57.8)mm vs 46.0(42.0~49.0)mm,P<0.05],肌酐水平升高[113.6(90.5~152.7)μmol/L vs 82.4(69.1~97.4)μmol/L,P<0.05]。相关性分析显示NT-proBNP和Gal-3与超声心动图指标(LVEF、LVEDD)之间均相关,其中Gal-3和NT-proBNP相关性(r=0.57,P<0.01)最强。受试者工作特征(ROC)曲线下面积Gal-3、NT-proBNP、LVEF分别为0.674(0.584~0.763)、0.837(0.771~0.902)、0.806(0.735~0.878)。提示NT-proBNP判别心力衰竭的能力最强。结论:Gal-3具有判别心力衰竭的能力,可以作为心力衰竭的标志物,但其判别心力衰竭的能力低于NT-proBNP。 Objective:To compare the effect of galectin-3(Gal-3),NT-proBNP and echocardiography paramerters on assessing cardiac function in patients with chronic heart failure(HF).Methods:A total of 144 patients treated in our hospital from 2016-03 to 2016-11 were enrolled.According to the NYHA classification,the patients were divided into 2 groups:HF group and Normal cardiac function group.n=72 in each group.Basic clinical information was collected,blood levels of Gal-3 and NT-proBNP were examined,echocardiography was conducted to measure left ventricular ejection fraction(LVEF) and left ventricular end diastolic diameter(LVEDD).Correlations between Gal-3,NT-proBNP and echocardiography parameters were studied,the abilities of Gal-3,NT-proBNP and echocardiography for estimating HF were compared.Results:Compared with Normal cardiac function group,HF group had increased blood levels of NT-proBNP [3499.5(1431.3-9088.0) ng/L] vs [384.1(122.1-1540.5) ng/L] and Gal-3 [3.0(1.71-5.8) pg/ml] vs [1.9(1.4-2.6) pg/ml],decreased LVEF [49.5%(42%-58%)] vs [62.5%(59%-67%)],enlarged LVEDD [52.0(46.3-57.8) mm] vs [46.0(42.0-49.0) mm] and elevated serumcreatinine [113.6(90.5-152.7) umol/L] vs 82.4(69.1-97.4) umol/L],all P〈0.05.Correlation analysis showed that NT-proBNP and Galectin-3 were positively related to LVEF and LVEDD;Gal-3 and NT-Pro BNP had the strongest correlation(r=0.57,P〈0.01).The AUC of ROC for Gal-3 was 0.674(0.584-0.763),for NT-proBNP was 0.837(0.771-0.902) and for LVEF was 0.806,(0.735-0.878) which implied that NT-proBNP was the most powerful parameter for estimating HF.Conclusion:Gal-3 had the ability to estimate HF and could be used as a biomarker,while its ability was lower than NTproBNP in clinical practice.
作者 杨玲玲 李树仁 郝清卿 郝潇 李沙 马玉龙 张跃华 邓文浩 YANG LING-ling, LI Shu-ren, HAO Qing-qing, HAO Xiao, LI Sha, MA Yu-long, ZHANG Yue-hua, DENG Wen-hao.(Graduate School of Hebei Medical University, Shijiazhuang (050000), Hebei, China)
出处 《中国循环杂志》 CSCD 北大核心 2018年第3期236-240,共5页 Chinese Circulation Journal
关键词 心力衰竭 半乳糖凝集素-3 N末端B型利钠肽原 Heart failure Galectin-3 NT-proBNP
  • 相关文献

参考文献5

二级参考文献70

  • 1中华医学会心血管病学分会.2007中国慢性心力衰竭诊断治疗指南.中华心血管病杂志,2007,. 被引量:23
  • 2陆再英,钟南山.内科学[M].北京:人民卫生出版社,2012:336-337. 被引量:47
  • 3Wassennan K HJ, Sue D, Stringer W, et al. Principles of exercise testing and interpretation [M J . 5 th Ed. Philadelphia: Lippincott Williams & Wilkins ,2011 : 1-8,194-234,285-299. 被引量:1
  • 4Guazzi M, Myers J, Arena R. Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure [J] . J Am Coll Cardiol, 2005, 46 ( 10) : 1883 -1890. 被引量:1
  • 5Group on Heart Failure of the European Society of Cardiology. Recommendations for exercise testing in chronic heart failure patients[J]. Eur Heart J, 2001,22(1) :3745. 被引量:1
  • 6Task Force of the Italian Working Group on Cardiac Rehabilitation and Prevention, Piepoli MF, Corm U, et al. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction. Recommendations for performance and interpretation [J]. Eur J Cardiovasc Prev Rehabil, 2006, 13 ( 1 ) : 10-12. 被引量:1
  • 7Mancini DM, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure [J] . Circulation, 1991,83(3) :778-786. 被引量:1
  • 8Myers J, Gullestad L, Vagelos R, et al. Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mUkg/ min revisitedj]]. Am Heart J, 2000,139(1 Pt 1) :78-84. 被引量:1
  • 9Arena R, Myers J, Aslam SS, et al. Peak V02 and VE/VC02 slope in patients with heart failure: a prognostic comparison [J] . Am Heart J, 2004,147(2) :354-360. 被引量:1
  • 10Sun XG, Hansen JE, Stringer WW. Oxygen uptake efficiency plateau best predicts early death in heart failure [J]. Chest, 2012, 141 (5) : 1284-1294. 被引量:1

共引文献91

同被引文献172

引证文献22

二级引证文献142

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部